Althea claims profitability ‘is close’ despite pharmaceutical nosedive by Steve Jones March 3, 2025March 4, 2025 Cost savings enabled Althea to narrow losses in the first half of FY25 as the company […]
Althea resumes trading on ASX as board narrowly avoids a second shareholder revolt by Steve Jones February 3, 2025February 3, 2025
Impairment charge sees Althea losses sink to $32m despite revenue growth by Steve Jones August 30, 2024September 2, 2024
Althea to cut further costs amid cash flow concerns and ongoing losses by Steve Jones March 1, 2024March 4, 2024
Althea heralds ‘turning point’ as firm makes first monthly operating profit by Steve Jones April 12, 2023April 30, 2024
Althea shares spike as revenue doubles and operating costs hit ‘all-time low’ by Steve Jones July 12, 2022April 29, 2024
Althea bets on dual strategy as CEO predicts big pharma will come knocking ‘sooner than we thought’ by Steve Jones September 23, 2021April 26, 2024
